Free Trial

Best Stocks Under $3 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Senseonics stock logo

1. Senseonics NYSE:SENS

$0.46 0.00 (-0.11%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.46 0.00 (-0.54%)
As of 08/29/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about Senseonics

Market Capitalization
$374.35 million
P/E Ratio
-3.53
Consensus Rating
Buy
Consensus Price Target
$1.54 (+234.6% Upside)
Volume
3.11 million shares
Average Volume
8.04 million shares
TuHURA Biosciences stock logo

2. TuHURA Biosciences NASDAQ:HURA

$2.70 -0.11 (-3.91%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.72 +0.02 (+0.74%)
As of 08/29/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$135.13 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+369.1% Upside)
Volume
220,226 shares
Average Volume
796,333 shares
Today's Range
$2.69
$2.82
Climb Bio stock logo

3. Climb Bio NASDAQ:CLYM

$2.23 -0.07 (-3.04%)
As of 08/29/2025 04:00 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$151.11 million
P/E Ratio
-3.19
Consensus Rating
Buy
Consensus Price Target
$9.00 (+303.6% Upside)
Volume
288,883 shares
Average Volume
878,948 shares
Western Copper & Gold stock logo

4. Western Copper & Gold NYSE:WRN

$1.41 -0.01 (-0.70%)
As of 08/29/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$282.78 million
P/E Ratio
-70.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+183.7% Upside)
Volume
519,590 shares
Average Volume
376,114 shares
Immunic stock logo

5. Immunic NASDAQ:IMUX

$0.82 -0.05 (-5.75%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.82 +0.00 (+0.37%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$80.89 million
P/E Ratio
-0.67
Consensus Rating
Buy
Consensus Price Target
$7.50 (+814.6% Upside)
Volume
1.37 million shares
Average Volume
1.09 million shares
Denison Mine stock logo

6. Denison Mine NYSEAMERICAN:DNN

$2.32 +0.12 (+5.45%)
Closing price 08/29/2025 04:10 PM Eastern
Extended Trading
$2.30 -0.02 (-0.86%)
As of 08/29/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$2.08 billion
P/E Ratio
-38.67
Consensus Rating
Buy
Consensus Price Target
$3.00 (+29.3% Upside)
Volume
75.12 million shares
Average Volume
56.15 million shares
ImmunityBio stock logo

7. ImmunityBio NASDAQ:IBRX

$2.34 +0.01 (+0.43%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.35 +0.01 (+0.21%)
As of 08/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.21 billion
P/E Ratio
-4.87
Consensus Rating
Buy
Consensus Price Target
$10.75 (+359.4% Upside)
Volume
5.62 million shares
Average Volume
9.02 million shares
Stardust Power stock logo

8. Stardust Power NASDAQ:SDST

$0.40 +0.00 (+0.40%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.41 +0.00 (+1.10%)
As of 08/29/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$33.97 million
P/E Ratio
-0.72
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,173.0% Upside)
Volume
528,391 shares
Average Volume
1.11 million shares
Mereo BioPharma Group stock logo

9. Mereo BioPharma Group NASDAQ:MREO

$1.71 -0.04 (-2.29%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.73 +0.02 (+1.17%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$271.89 million
P/E Ratio
-24.43
Consensus Rating
Buy
Consensus Price Target
$7.40 (+332.7% Upside)
Volume
695,500 shares
Average Volume
1.31 million shares
zSpace stock logo

10. zSpace NASDAQ:ZSPC

$2.11 -0.10 (-4.52%)
As of 08/29/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$50.33 million
Consensus Rating
Buy
Consensus Price Target
$10.00 (+373.9% Upside)
Volume
105,564 shares
Average Volume
102,368 shares
Today's Range
$2.05
$2.31
FibroBiologics stock logo

11. FibroBiologics NASDAQ:FBLG

$0.59 -0.03 (-4.85%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.60 +0.01 (+2.19%)
As of 08/29/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$24.72 million
P/E Ratio
-1.64
Consensus Rating
Buy
Consensus Price Target
$13.00 (+2,103.0% Upside)
Volume
342,935 shares
Average Volume
459,646 shares
NRx Pharmaceuticals stock logo

12. NRx Pharmaceuticals NASDAQ:NRXP

$2.32 -0.20 (-7.94%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.35 +0.03 (+1.08%)
As of 08/29/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$45.96 million
P/E Ratio
-1.04
Consensus Rating
Buy
Consensus Price Target
$28.50 (+1,128.4% Upside)
Volume
569,458 shares
Average Volume
472,681 shares
Ur Energy stock logo

13. Ur Energy NYSEAMERICAN:URG

$1.39 0.00 (0.00%)
Closing price 08/29/2025 04:10 PM Eastern
Extended Trading
$1.40 +0.01 (+0.43%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$507.11 million
P/E Ratio
-8.18
Consensus Rating
Buy
Consensus Price Target
$2.48 (+78.1% Upside)
Volume
6.65 million shares
Average Volume
4.27 million shares
FiscalNote stock logo

14. FiscalNote NYSE:NOTE

$0.43 +0.01 (+1.19%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$0.42 -0.01 (-1.41%)
As of 08/29/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$73.15 million
P/E Ratio
-1.33
Consensus Rating
Buy
Consensus Price Target
$29.25 (+6,766.2% Upside)
Volume
2.13 million shares
Average Volume
2.97 million shares
Quince Therapeutics stock logo

15. Quince Therapeutics NASDAQ:QNCX

$1.60 +0.06 (+3.90%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.56 -0.04 (-2.44%)
As of 08/29/2025 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$85.94 million
P/E Ratio
-1.47
Consensus Rating
Buy
Consensus Price Target
$8.14 (+408.9% Upside)
Volume
224,871 shares
Average Volume
194,743 shares
Ovid Therapeutics stock logo

16. Ovid Therapeutics NASDAQ:OVID

$1.28 +0.03 (+2.40%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.25 -0.03 (-2.34%)
As of 08/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$91.02 million
P/E Ratio
-2.42
Consensus Rating
Buy
Consensus Price Target
$3.10 (+142.2% Upside)
Volume
1.87 million shares
Average Volume
1.77 million shares
Biomea Fusion stock logo

17. Biomea Fusion NASDAQ:BMEA

$1.95 +0.03 (+1.56%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.94 -0.01 (-0.77%)
As of 08/29/2025 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea Fusion

Market Capitalization
$116.04 million
P/E Ratio
-0.64
Consensus Rating
Buy
Consensus Price Target
$14.80 (+659.0% Upside)
Volume
590,011 shares
Average Volume
672,859 shares
Nuvation Bio stock logo

18. Nuvation Bio NYSE:NUVB

$2.98 +0.06 (+1.88%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$2.94 -0.03 (-1.01%)
As of 08/29/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nuvation Bio Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. More about Nuvation Bio

Market Capitalization
$1.02 billion
P/E Ratio
-4.72
Consensus Rating
Buy
Consensus Price Target
$7.33 (+146.5% Upside)
Volume
2.39 million shares
Average Volume
4.78 million shares
Context Therapeutics stock logo

19. Context Therapeutics NASDAQ:CNTX

$0.84 -0.01 (-1.20%)
As of 08/29/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$75.35 million
P/E Ratio
-2.33
Consensus Rating
Buy
Consensus Price Target
$5.25 (+525.0% Upside)
Volume
82,615 shares
Average Volume
172,341 shares
Black Diamond Therapeutics stock logo

20. Black Diamond Therapeutics NASDAQ:BDTX

$2.75 -0.10 (-3.51%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.80 +0.05 (+1.82%)
As of 08/29/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Black Diamond Therapeutics, Inc, a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. More about Black Diamond Therapeutics

Market Capitalization
$156.57 million
P/E Ratio
11.96
Consensus Rating
Buy
Consensus Price Target
$12.40 (+350.9% Upside)
Volume
563,573 shares
Average Volume
871,646 shares
Reviva Pharmaceuticals stock logo

21. Reviva Pharmaceuticals NASDAQ:RVPH

$0.45 -0.01 (-2.24%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.46 +0.01 (+1.33%)
As of 08/29/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$30.60 million
P/E Ratio
-0.69
Consensus Rating
Buy
Consensus Price Target
$5.20 (+1,055.6% Upside)
Volume
1.23 million shares
Average Volume
2.32 million shares
OnKure Therapeutics stock logo

22. OnKure Therapeutics NASDAQ:OKUR

$2.75 -0.06 (-2.14%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.78 +0.02 (+0.91%)
As of 08/29/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$37.21 million
P/E Ratio
-0.57
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,075.8% Upside)
Volume
37,314 shares
Average Volume
128,496 shares
ProQR Therapeutics stock logo

23. ProQR Therapeutics NASDAQ:PRQR

$2.25 +0.06 (+2.74%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.20 -0.04 (-2.00%)
As of 08/29/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR Therapeutics

Market Capitalization
$236.73 million
P/E Ratio
-4.89
Consensus Rating
Buy
Consensus Price Target
$8.00 (+255.6% Upside)
Volume
152,458 shares
Average Volume
318,862 shares
Aclaris Therapeutics stock logo

24. Aclaris Therapeutics NASDAQ:ACRS

$1.93 +0.09 (+4.89%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.92 -0.01 (-0.78%)
As of 08/29/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$209.08 million
P/E Ratio
-1.41
Consensus Rating
Buy
Consensus Price Target
$8.71 (+351.5% Upside)
Volume
831,137 shares
Average Volume
739,519 shares
Adicet Bio stock logo

25. Adicet Bio NASDAQ:ACET

$0.72 -0.04 (-5.09%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$0.74 +0.02 (+2.50%)
As of 08/29/2025 06:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adicet Bio, Inc, a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. More about Adicet Bio

Market Capitalization
$59.94 million
P/E Ratio
-0.55
Consensus Rating
Buy
Consensus Price Target
$6.00 (+733.3% Upside)
Volume
196,987 shares
Average Volume
683,217 shares